Keegan to Lead Strategic Growth and Drive AI-Enabled Innovation in Digital Cognitive Health Solutions ...
Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.
Tuesday, Sage Therapeutics, Inc. (NASDAQ:SAGE) released topline results from the Phase 2 LIGHTWAVE study to evaluate the ...
When most people think of dementia, including Alzheimer's disease, they probably think of memory loss first.But dementia also changes the way a person ...
Researchers have illustrated that synthetic cannabis can reduce agitation in Alzheimer's patients by an average of 30%.
Early Dementia Questionnaire (EDQ) This questionnaire (Additional file 1) was developed based on combination of literature review, expert opinion and standardized assessment tools. The literature ...
HotCopper.com on MSN6d
PainChek close to finding out if FDA approves its flagship app for use in dementia carePainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in ...
Backed by a $25 million, five-year federal grant from the National Institute on Aging, USC's Center for Economic and Social ...
VitalCaring has announced the results of a seven-month AI-driven cognitive care pilot program. The program provided personalized therapy to patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback